Article
Leukocyte telomere length and renal cell carcinoma survival in two studies
25 Jul 2017
Abstract excerpt
BACKGROUND: Leukocyte telomere length (LTL) is a potential biomarker of cancer prognosis; however, evidence for renal cell carcinoma (RCC) is inconsistent. METHODS: We investigated LTL and RCC-specific survival among 684 cases from the US kidney cancer study (USKC) and 241 cases from the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO). Leukocyte telomere length was measured by quantitative...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
